Ann E. Taylor

Ann E. Taylor, M.D., is an experienced R&D leader with over 35 years in exploratory research and early clinical development. Ann has held significant positions, including Vice President of Global Clinical Development at MedImmune and Chief Medical Officer at Astra Zeneca. Currently, Ann serves on multiple boards, including Unlearn.AI, Comanche Biopharma, and the TB Alliance. Educated at the University of California San Diego, Ann earned a B.A. in Biology, graduating magna cum laude, and is also affiliated with Harvard Medical School.